Church & Dwight Co., Inc. (CHD) Stock Forecast
Data as of May 2, 2026Consumer Defensive · Current price $95.72 (-1.40%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 9, 2026 | Dwight to | RBC Capital | $112.00 | +17.0% |
| Feb 13, 2026 | Edward Lewis | Redburn Partners | $91.00 | -4.9% |
| Jan 5, 2026 | Olivia Tong | Raymond James | $100.00 | +4.5% |
| Dec 16, 2025 | Kaumil Gajrawala | Jefferies | $102.00 | +6.6% |
| Dec 10, 2025 | Steve Powers | Deutsche Bank | $100.00 | +4.5% |
| Jul 14, 2025 | Edward Lewis | Redburn Partners | $83.00 | -13.3% |
| Jun 6, 2025 | Bill Chappell | Truist Financial | $110.00 | +14.9% |
| Nov 4, 2024 | Kaumil Gajrawala | Jefferies | $108.00 | +12.8% |
| Sep 23, 2024 | Korinne Wolfmeyer | Piper Sandler | $120.00 | +25.4% |
| Aug 5, 2024 | Mark Astrachan | Stifel Nicolaus | $105.00 | +9.7% |
| Aug 5, 2024 | Javier Escalante | Evercore ISI | $101.00 | +5.5% |
| Aug 5, 2024 | Andrea Teixeira | J.P. Morgan | $97.00 | +1.3% |
| Jun 3, 2024 | Phillip Jungwirth | BMO Capital | $115.00 | +20.1% |
| May 3, 2024 | Alejandro Zamacona | HSBC | $110.00 | +14.9% |
| May 3, 2024 | Ana Garcia | CFRA | $114.00 | +19.1% |
| Apr 23, 2024 | Rupesh Parikh | Oppenheimer | $120.00 | +25.4% |
| Feb 23, 2024 | Taylor Conrad | Argus Research | $115.00 | +20.1% |
| Nov 3, 2023 | Steve Powers | Deutsche Bank | $110.00 | +14.9% |
| Nov 3, 2023 | Lauren Lieberman | Barclays | $76.00 | -20.6% |
| Oct 23, 2023 | Dara Mohsenian | Morgan Stanley | $114.00 | +19.1% |
Top Analysts Covering CHD
CHD vs Sector & Market
| Metric | CHD | Consumer Defensive Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.67 | 2.55 | 2.41 |
| Analyst Count | 21 | 12 | 18 |
| Target Upside | +4.0% | +1188.9% | +14.9% |
| P/E Ratio | 31.80 | -7.42 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $6.12B | $6.14B | $6.18B | 14 |
| 2027-03-31 | $1.49B | $1.51B | $1.53B | 4 |
| 2027-06-30 | $1.55B | $1.57B | $1.59B | 4 |
| 2027-09-30 | $1.60B | $1.62B | $1.64B | 5 |
| 2027-12-31 | $1.66B | $1.68B | $1.70B | 4 |
| 2028-03-31 | $1.55B | $1.57B | $1.59B | 3 |
| 2028-06-30 | $1.60B | $1.62B | $1.64B | 3 |
| 2028-09-30 | $1.66B | $1.68B | $1.70B | 5 |
| 2028-12-31 | $1.73B | $1.75B | $1.78B | 3 |
| 2029-12-31 | $6.82B | $6.87B | $7.05B | 7 |
| 2030-12-31 | $7.09B | $7.14B | $7.32B | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $3.61 | $3.75 | $3.85 | 12 |
| 2027-03-31 | $0.96 | $0.98 | $1.00 | 5 |
| 2027-06-30 | $1.01 | $1.03 | $1.04 | 5 |
| 2027-09-30 | $0.95 | $0.96 | $0.98 | 5 |
| 2027-12-31 | $0.99 | $1.00 | $1.02 | 5 |
| 2028-03-31 | $1.06 | $1.08 | $1.10 | 7 |
| 2028-06-30 | $1.03 | $1.05 | $1.07 | 6 |
| 2028-09-30 | $1.03 | $1.05 | $1.07 | 6 |
| 2028-12-31 | $1.05 | $1.07 | $1.09 | 7 |
| 2029-12-31 | $4.50 | $4.54 | $4.69 | 1 |
| 2030-12-31 | $4.66 | $4.71 | $4.87 | 1 |
Frequently Asked Questions
What is the analyst consensus for CHD?
The consensus among 21 analysts covering Church & Dwight Co., Inc. (CHD) is Hold with an average price target of $98.40.
What is the highest price target for CHD?
The highest price target for CHD is $120.00, set by Korinne Wolfmeyer at Piper Sandler on 2024-09-23.
What is the lowest price target for CHD?
The lowest price target for CHD is $76.00, set by Lauren Lieberman at Barclays on 2023-11-03.
How many analysts cover CHD?
21 analysts have issued ratings for Church & Dwight Co., Inc. in the past 12 months.
Is CHD a buy or sell right now?
Based on 21 analyst ratings, CHD has a consensus rating of Hold (2.67/5) with a +4.0% upside to the consensus target of $98.40.
What are the earnings estimates for CHD?
Analysts estimate CHD will report EPS of $3.75 for the period ending 2026-12-31, with revenue estimated at $6.14B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.